Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Pavlides

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Hepatology (Baltimore, Md.)|March 30, 2023
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation studyJenny Lee, Max Westphal, Yasaman Vali, et al.
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2024
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Eclinicalmedicine|January 25, 2021
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital dischargeBetty Raman, Mark Philip Cassar, Elizabeth M Tunnicliffe, et al.
Medcomm|November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter StudyJing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Hepatology (Baltimore, Md.)|March 16, 2023
Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetesGrazia Pennisi, Marco Enea, Vincenzo Falco, et al.
Hepatology (Baltimore, Md.)|March 30, 2023
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation studyJenny Lee, Max Westphal, Yasaman Vali, et al.
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2024
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Hepatobiliary Surgery and Nutrition|June 23, 2023
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney diseaseDan-Qin Sun, Giovanni Targher, Christopher D Byrne, et al.
Eclinicalmedicine|January 25, 2021
Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital dischargeBetty Raman, Mark Philip Cassar, Elizabeth M Tunnicliffe, et al.
Medcomm|November 27, 2025
Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter StudyJing Zhao, Ferenc E Mózes, Xin-Yu Xu, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Gut|May 18, 2021
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysisFerenc Emil Mózes, Jenny A Lee, Emmanuel Anandraj Selvaraj, et al.
The Lancet. Gastroenterology & Hepatology|June 8, 2023
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Pageof 7